Go a long way, waiting for a large number of factories to close it. I

U.S. Department of Justice announced Monday that Johnson & Johnson (JNJ) has agreed to pay $ 2.2 billion dm to settle about its offer rebates and illegal marketing of drugs to doctors dm and pharmacies for unapproved uses of criminal and civil investigations. The settlement involves Johnson & Johnson and its subsidiary Janssen Pharmaceutica. U.S. Department of Justice announced Monday that Johnson dm & Johnson (JNJ) has agreed to pay $ 2.2 billion to settle about its offer rebates and illegal marketing of drugs to doctors and pharmacies for unapproved uses of criminal and civil investigations. The settlement involves Johnson & Johnson and its subsidiary Janssen Pharmaceutica, drugs involved include the treatment of schizophrenia medication Risperdal, antipsychotic Invega, and the heart medication Natrecor. Previously, Johnson & Johnson will face a $ 2.2 billion ticket news, who set off an uproar. This is where the focus is, someone's drug Risperdal (risperidone Chinese name) is also in the Chinese market sales. The public is very confused, this same drug, the same sales model, Why is illegal in foreign countries, while in China, but no problem. Today, Johnson & Johnson has agreed to pay the sum fine. It is said that a total fine of $ 2.2 billion of which has $ 1.72 billion civil settlement payments are paid to the U.S. federal and state governments, and another $ 485 million in criminal fines and confiscation of profits. Well, then down, in the Chinese market, also a medicine, what kind of consequences? Admittedly, we might sad to see that this medicine in China is "permitted" in. In the case of Johnson, the U.S. Food and Drug Administration declared unapproved drug for the treatment of bipolar disorder in this indication, according to the company strong children - Janssen's description, the indications in China has officially dm approved, off-label promotion problem does not exist. This statement is not exactly true? If so, in the domestic market, why is this in the same way pharmaceutical companies sell the same drugs, but it is legitimate? Could it really is a monk chanting?, We found that Johnson & Johnson this time $ 2.2 billion a ticket, not the first time. In April 11, 2012, Arkansas judge ruling, Johnson & Johnson (JNJ) and its subsidiaries dm will be a lesson to more than $ 1.1 billion in fines, on the grounds that a jury had found that the two companies weakened or conceal a risk of antipsychotic drugs Risperdal. September 15, 2011, the company produced strong children with heart failure medication Natrecor identify improper fined $ 85 million. June 2011 9, the day Johnson dm & Johnson subsidiary due to the presence of antipsychotic drugs "deceptive advertising" led to a lawsuit, fined $ 327 million. April 9, 2011, on suspicion of overseas multinational with bribes, kickbacks means the sale of drugs in exchange for signing a contract indicted, dm U.S. law enforcement and regulatory agencies have to pay $ 70 million to reach a settlement. This last one is most ironic that this referred overseas, would definitely be included dm in the Chinese market. This local companies overseas violations, the authorities decided to open a ticket. dm In the so-called "overseas" such as China, Johnson's days were very moist. Astronomical dm fines for China, almost never opened such a large list. There is no doubt that for Johnson, this point is simply a fine drizzle, nowhere near this approach, it is true does not make Johnson feel heartache. Moreover, in the Chinese market, there are many things in the United States must NO locally, where it becomes a YES. Shigenori be disorder in, but unfortunately here we chose silence. Undoubtedly, the relevant departments of silence, so this will be more and more foreign monks chanting it. Original Link: http://expert.brandcn.com Discussion dm Share to ... Copy Link Bury Add to: | Favorites
Related Documents Johnson - objection Management 38 Johnson & Johnson - Basic call step 25 Johnson - arranged Visits 25 U.S. Johnson & Johnson Case 18 Johnson crisis PR Case 5 Johnson Internet Marketing Case Studies 7 Johnson armor powder case analysis 17 Strategic Management - Case 2 Johnson & Johnson Johnson & Johnson Internet marketing strategy analysis of seven DNA chips Johnson & Johnson business plan 71 more documents fines Business Analysis [Johnson]
Go a long way, waiting for a large number of factories to close it. I'm sorry ... really people, especially foreign trade sorry people. ... Thanks for sharing ... learn, dm thanks for sharing ... the sun ... Link chaos ... it makes sense to split the gold reserve ... China should be to maintain dm China this "food chain" dm normal .. They contend it is eventually passed anyway. ... So perfect cadre oh ... less and less hair restoration planning regulations in France ... product management strategy impressive. ... Do not agree! Article mislead young people. Most people work all hold ... Oh, time to worry hardship. Like a sponge-like non-selective, purposeful drain ... Thank you for correcting dm me, the original has been corrected! More ...